BC thanks for this helpful information but are these treatments widely available? My understanding from a WaPo article was that there isn't enough of the proven medicines -- whether remdesivir or the antibody cocktails -- for most people. It's helpful to know that these drugs exist and people can ask for them, but it sounds like the vast majority of people would be out of luck unless they have some personal connection to the Trump administration, and even then, only *some* of theme seem to get the VIP treatment (certainly not Herman Cain).
From the WaPo:
Giuliani, 76, joins a group of other Trump confidants who have received special care that is not widely available.
“The treatment given to Mr. Trump’s allies is raising alarms among medical ethicists as state officials and health system administrators grapple with gut-wrenching decisions about which patients get antibodies,” the New York Times reports. “Some top officials at the F.D.A. — both career employees and political appointees — have privately expressed concern in recent months that people with connections to the White House appeared to be getting access to the antibody treatments. … The antibody treatments are so scarce that officials in Utah have developed a ranking system to determine who is most likely to benefit from the drugs, while Colorado is using a lottery system. … The scarcity is such a problem that the National Academies of Sciences, Engineering and Medicine is holding a session next week to help medical professionals sort their way through rationing questions.”
Former New Jersey governor Chris Christie got the Eli Lilly antibodies before the FDA granted an emergency use authorization for them. The 58-year-old was offered participation in a Regeneron clinical trial but turned it down because he feared he might receive a placebo, the Times notes.
From the WaPo:
Giuliani, 76, joins a group of other Trump confidants who have received special care that is not widely available.
“The treatment given to Mr. Trump’s allies is raising alarms among medical ethicists as state officials and health system administrators grapple with gut-wrenching decisions about which patients get antibodies,” the New York Times reports. “Some top officials at the F.D.A. — both career employees and political appointees — have privately expressed concern in recent months that people with connections to the White House appeared to be getting access to the antibody treatments. … The antibody treatments are so scarce that officials in Utah have developed a ranking system to determine who is most likely to benefit from the drugs, while Colorado is using a lottery system. … The scarcity is such a problem that the National Academies of Sciences, Engineering and Medicine is holding a session next week to help medical professionals sort their way through rationing questions.”
Former New Jersey governor Chris Christie got the Eli Lilly antibodies before the FDA granted an emergency use authorization for them. The 58-year-old was offered participation in a Regeneron clinical trial but turned it down because he feared he might receive a placebo, the Times notes.